Cellares
Trending Articles
Related Content
Design & Build
Cellares' closed automated cell therapy system gets new industry partner
Poseida Therapeutics has agreed to provide insight into autologous and allogeneic CAR-T workflows, as well as emerging programs that include TCR-T, genetically modified NK cells, and other cell therapy manufacturing workflows for Cellares Corporation